Executive leadership at Vita Coco Company, Inc. (NASDAQ: COCO) has engaged in significant equity activity. Jonathan Burth, serving as the company's Chief Operating Officer, executed transactions involving 60,000 shares of common stock on April 29 and April 30, 2026. The total value of these sales reached roughly $3.9 million, with share prices fluctuating between $62.50 and $67.50 during the sessions.
The transaction sequence began with Mr. Burth exercising options to acquire 60,000 shares of Vita Coco common stock. These options were fully vested and eligible for immediate exercise. The cost associated with acquiring these shares through the exercise price was $10.178 per share, resulting in a total expenditure of $610,680.
Immediately following this acquisition, Mr. Burth sold the entirety of the 60,000 shares under the framework of a Rule 10b5-1 trading plan. The breakdown of the sales is as follows:
- April 29: 20,000 shares were sold at $65.00 per share, and another 20,000 shares were sold at $62.50 per share.
- April 30: The remaining 20,000 shares were sold at a price of $67.50 per share.
Post-transaction, Mr. Burth retains a direct holding of 57,910 shares of Vita Coco common stock. Additionally, he continues to hold various non-qualified stock options that feature different expiration dates and vesting schedules, some extending as far as March 4, 2035.
This insider activity follows a period of high financial performance for the company. Vita Coco's fiscal first-quarter 2026 results indicated a significant surge in revenue, with sales hitting $180 million. This figure represents a 37% year-over-year increase and surpassed the expectations set by both Visible Alpha Consensus ($149.2 million) and BofA Securities ($149.6 million).
Profitability metrics also exceeded market forecasts. The company reported a net income of $30 million, which translates to $0.50 per diluted share, outperforming the projected $0.315 per share. Furthermore, adjusted EBITDA reached $38.7 million, notably higher than the Street expectation of $26.0 million.
Market analysts have reacted with optimism to these financial milestones. BofA Securities maintained a Buy rating while increasing its price target for the stock to $72. Similarly, Evercore ISI raised its price target from $70 to $75, upholding an Outperform rating. Despite this positive momentum and investor optimism, analysis suggests that the stock currently appears overvalued relative to its calculated Fair Value.